Stock Price Forecast

March 18, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Applied Therapeutics Inc chart...

About the Company

applied therapeutics, inc. is a hospital and health care company located in 3104 cherry palm dr, tampa, fl, united states.

Exchange

NASDAQ

Website

http://www.appliedtherapeutics.com/

$14M

Total Revenue

31

Employees

$506M

Market Capitalization

-5.00

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $APLT News

Applied Therapeutics (APLT) Surges 124% in a Month: Here's Why

5d ago, source: Hosted on MSN

Applied Therapeutics, Inc. APLT, a clinical-stage company, is currently focused on developing novel therapies against rare ...

Applied Therapeutics Inc (APLT) Announces Year-End 2023 Financial Results and Clinical Progress

10d ago, source:

Financing: Completed a $100 million Private Placement, extending cash runway into 2026.

Applied Therapeutics Reports Fourth Quarter and Year-end 2023 Financial Results

12d ago, source:

NDA for govorestat accepted and granted Priority Review by FDA for the treatment of Classic Galactosemia; PDUFA target action date of August 28, ...

Applied Therapeutics Rallies After Announcing Private Placement Of Shares

19d ago, source:

(RTTNews) - Shares of Applied Therapeutics, Inc. (APLT) are surging more than 40 percent Wednesday morning after the clinical-stage biopharmaceutical company announced a private placement to the tune ...

Analysts Offer Insights on Healthcare Companies: Applied Therapeutics (APLT), Xeris Pharmaceuticals (XERS) and Arcturus Therapeutics (ARCT)

7d ago, source:

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Applied Therapeutics (APLT – Research ...

Cyclo Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update

14h ago, source:

Cyclo Therapeutics, Inc. (Nasdaq: CYTH) ("Cyclo Therapeutics" or the "Company"), a clinical stage biotechnology company dedicated to developing life-changing medicines through science and innovation ...

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Q4 2023 Earnings Call Transcript

10d ago, source: InvestingChannel on MSN

March 7, 2024 Arcturus Therapeutics Holdings Inc. beats earnings expectations. Reported EPS is $-0.32, expectations were ...

Allogene Therapeutics, Inc.: Allogene Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Update

4d ago, source: Finanznachrichten

March 14, 2024 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology ... ALLO-329: CD19 Dagger ® in Autoimmune Disease (AID) The Company has applied its deep ...

Applied DNA Sciences, Inc.: Applied DNA to Showcase Linea DNA and Linea IVT Platforms at 24th Annual World Vaccine Congress

4d ago, source:

STONY BROOK, NY / ACCESSWIRE / March 14, 2024 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA), a leader in PCR-based DNA technologies, will showcase its Linea IVT and Linea DNA platforms at t ...

Q4 2023 Allogene Therapeutics Inc Earnings Call

3d ago, source: Yahoo Finance

Christine Cassiano; EVP, Chief Corporate Affairs and Brand Strategy Officer; Allogene Therapeutics Inc David Chang ... are relative nadir is a very interesting proposition and can be applied to other ...

Applied DNA to Showcase Linea(TM) DNA and Linea(TM) IVT Platforms at 24th Annual World Vaccine Congress

5d ago, source: PharmiWeb

STONY BROOK, NY / ACCESSWIRE / March 14, 2024 / Applied DNA Sciences ... DNA for use in the production of nucleic acid-based therapeutics and, through our recent acquisition of Spindle Biotech, Inc. ( ...

Q4 2023 Arcturus Therapeutics Holdings Inc Earnings Call

10d ago, source: Yahoo Finance

Neda Safarzadeh; VP of IR, Public Relations, and Marketing; Arcturus Therapeutics Holdings, Inc. Joe Payne; President and CEO ... Our validated vaccine platform is now being applied to seven global ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...